EUVIMEDObjevte EUVIMED
MetaanalyseSystematische ÜbersichtOpen access

Consumer-Grade Neurofeedback With Mindfulness Meditation: Meta-Analysis

Isaac Treves iD, Zia Bajwa iD, Keara D Greene iD, Paul A Bloom iD, Nayoung Kim iD, Emma Wool iD, Simon B Goldberg iD, Susan Whitfield-Gabrieli iD, Randy P Auerbach iD

Journal of Medical Internet Research · 2025-04-17 · 27 · e68204

DOI: 10.2196/68204 ↗

At a glance

Metaanalyse in Journal of Medical Internet Research, published online on 2025-04-17. Written by Isaac Treves and 8 co-authors. Institution: McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States. Major MEDLINE topics: Meditation, Mindfulness, Neurofeedback. Cited 15 times so far (Crossref); 130 references. The full text is freely available in PubMed Central. Funded by: NCCIH NIH HHS, NIMH NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

There is burgeoning interest in the application of neuroscientific technology to facilitate meditation and lead to beneficial psychological outcomes. One popular approach is using consumer-grade neurofeedback devices to deliver feedback on brain targets during meditation (mindfulness-based neurofeedback). It is hypothesized that optimizing brain targets like alpha and theta band activity may allow meditators to experience deeper mindfulness and thus beneficial outcomes.

Objective

This study aimed to systematically review and meta-analyze the impacts of consumer-grade mindfulness-based neurofeedback compared with control conditions. Included studies involved mindfulness practice operationalized as open monitoring or focused attention meditation. This study was preregistered.

Methods

A total of 16 randomized controlled training trials, as well as 5 randomized within-participant designs were included, encompassing 763 and 167 unique participants, respectively. Effects were categorized outcomes (ie, psychological distress, cognitive function, and physiological health) and process variables (ie, state mindfulness and brain measures). Study risk of bias, reporting bias, and publication bias were assessed.

Results

Samples were typically small (n=30-50), and the majority of studies used mindfulness apps as controls. To deliver neurofeedback, most studies used the Muse device (11/16 randomized controlled trials [RCTs]). There was a modest effect for decreases in psychological distress compared with controls (k=11, g=–0.16, P=.03), and heterogeneity was low (I2< 0.25). However, there was no evidence for improvements in cognition (k=7, g=0.07, P=.48), mindfulness (k=9, g=0.02, P=.83), and physiological health (k=7, g=0.11, P=.57) compared to controls. Mechanistic modulation of brain targets was not found in RCTs or within-participant designs. Sex (male or female), age, clinical status, study quality, active or passive controls, sample size, and neurofeedback duration did not moderate effects. There was some evidence for reporting bias, but no evidence of publication bias. Adverse effects were not assessed in 19 out of 21 studies and not found in the 2 studies that assessed them.

Conclusions

Assertions that consumer-grade devices can allow participants to modulate their brains and deepen their meditations are not currently supported. It is possible that neurofeedback effects may rely on “neurosuggestion” (placebo effects of neurotechnology). Future research should examine more extensive calibration and individualization of devices, larger sample sizes, and gold-standard sham-controlled RCTs.

Subjects

MeSH terms (MEDLINE)

MeditationMindfulnessNeurofeedbackHumansRandomized Controlled Trials as Topic

Author keywords

Musecognitionconsumer gradedevicemeditationmeta-analysesmindfulnessneurofeedbackneuroscientific technologyneurotechnologiesneurotechnologyrandomizedstress

Authors and institutions

  • McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Department of Psychology, University of California, Berkeley, CA, United States.
  • Center for Precision Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
  • Department of Psychiatry, Columbia University, New York City, NY, United States.
  • Department of Counseling Psychology, University of Wisconsin-Madison, Madison, WI, United States.

ORCID profiles: Isaac Treves, Zia Bajwa, Keara D Greene, Paul A Bloom, Nayoung Kim, Emma Wool, Simon B Goldberg, Susan Whitfield-Gabrieli, Randy P Auerbach

Funding

  • NCCIH NIH HHS
  • NIMH NIH HHS

Cite

APA

Treves, I., Bajwa, Z., Greene, K. D., Bloom, P. A., Kim, N., Wool, E., Goldberg, S. B., Whitfield-Gabrieli, S., & Auerbach, R. P. (2025). Consumer-Grade Neurofeedback With Mindfulness Meditation: Meta-Analysis. Journal of Medical Internet Research, 27, e68204. https://doi.org/10.2196/68204

Vancouver

Treves I, Bajwa Z, Greene KD, Bloom PA, Kim N, Wool E, et al. Consumer-Grade Neurofeedback With Mindfulness Meditation: Meta-Analysis. Journal of Medical Internet Research. 2025;27:e68204. doi:10.2196/68204

BibTeX
@article{Treves2025,
  author = {Treves, Isaac and Bajwa, Zia and Greene, Keara D and Bloom, Paul A and Kim, Nayoung and Wool, Emma and Goldberg, Simon B and Whitfield-Gabrieli, Susan and Auerbach, Randy P},
  title = {Consumer-Grade Neurofeedback With Mindfulness Meditation: Meta-Analysis},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e68204},
  doi = {10.2196/68204}
}
Start for free →